exosomes/extracellular vesicles
City of Hope, TGen Win $4.5M Grant to Advance Pancreatic Cancer Liquid Biopsy Screening
A City of Hope-led consortium aims to validate a noninvasive screening test for pancreatic ductal adenocarcinoma in a large-scale, diverse cohort.
Sylvester Comprehensive Cancer Center Wins $2.5M NCI Grant to Develop Prostate Cancer Test
The team will work with collaborators at Bio-Techne's Exosome Diagnostics to develop its prostate cancer biomarker on a new platform.
The new data found that patients identified as low risk by the test received fewer biopsies and were less likely to be diagnosed later with high-grade prostate cancer.
Mercy BioAnalytics Raises $41M in Series A Financing
The proceeds will help develop and commercialize its extracellular vesicle-based Mercy Halo platform for lung, ovarian, and other cancer screening tests.
Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test
Research companies Curta and Qure Healthcare will be conducting an economic modeling and physician behavior study, respectively.
Aug 18, 2022
Aug 16, 2022
Jun 30, 2022